Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort

1. 5.

   Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) · 2020

2. 8.

   Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients · 2020

3. 10.

   Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection · 2020

4. 11.

   Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients · 2020

5. 12.

   Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients · 2020

6. 14.

   Robust neutralizing antibodies to SARS-CoV-2 infection persist for months · 2020

7. 18.

   Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection · 2021

8. 25.

   Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination · 2021

9. 28.

   Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection · 2021

10. 30.

    Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants · 2021

11. 35.

    Immunity to SARS‐CoV‐2 induced by infection or vaccination · 2021

28 more references, whose wording the paper’s licence keeps private.

• Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors · 2022

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.